UT San Antonio

Clinical Researchers

Vincent Mysliwiec, MD, FAASM

Vincent Mysliwiec, MD, FAASM, is a leading expert in sleep and sleep disorders in military personnel and veterans. Dr. Mysliwiec has over 15 years of experience conducting research in military populations and has authored over 70 scientific manuscripts. His research has led to insights into the clinical sleep disorders military personnel and veterans have, to include comorbid insomnia and obstructive sleep apnea and the proposed parasomnia, trauma associated sleep disorder. His current research includes the largest study to date, evaluating gender differences in sleep disorders in military men and women, further development of trauma associated sleep disorder and the first questionnaire to evaluate sleep disorders in military personnel.



Research Areas
Clinical Research


Tiffany Kautz, PhD

Research focuses upon identifying biomarkers for earlier identification of Alzheimer’s disease and related neurodegenerative diseases. Actively involved in coordinating research collaborations to further these research interests, including the Markers for Vascular Contributions to Cognitive Impairment and Dementia (MarkVCID) and Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC). Also serves as the creator and coordinator of the Biggs Biobank, a comprehensive repository of biofluids and tissues from a variety of neurodegenerative disorders as well as cognitively healthy controls.



Research Areas
Clinical Research


Rebecca Hoyumpa, DNP, FNP-BC



Research Areas
Clinical Research


Sarah Horn, MD

Sarah Horn, MD, is a movement disorders specialist with expertise in the diagnosis and management of Parkinson’s disease and related neurodegenerative parkinsonian disorders. Dr. Horn has an interest in comparative effectiveness research and clinical trials and is currently the principal investigator for an actively enrolling pragmatic clinical trial funded by the Alzheimer’s Association studying the long-term effects of quetiapine versus pimavanserin for psychosis associated with Parkinson’s disease and dementia with Lewy bodies in a real-world setting.



Research Areas
Clinical Research